Vimarsana
Biggest News Aggregation in the World

Page 31 - Resented News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Resented. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Resented Today - Breaking & Trending Today

Shane Eleniak Named a Top 20 Chief Product Officer Worldwide, Once Again Demonstrating That Calix Is the Innovation Leader for the Broadband Industry - Vimarsana News

Shane Eleniak Named a Top 20 Chief Product Officer Worldwide, Once Again Demonstrating That Calix Is the Innovation Leader for the Broadband Industry

Eleniak is recognized with the Global CPO Top 20 Award, presented by Products That Count, for pioneering the broadband industry’s only end-to-end cloud and software platform that enables... | May 3, 2023

SIFI S.p.A.: SIFI PRESENTED NEW DATA ON XANTERDES AT ARVO 2023 - Vimarsana News

SIFI S.p.A.: SIFI PRESENTED NEW DATA ON XANTERDES AT ARVO 2023

CATANIA, Italy, May 2, 2023 /PRNewswire/ -- SIFI, a leading pharmaceutical company in the development of innovative solutions for the treatment of eye diseases, presented a series of scientific

Telix Pharmaceuticals Limited: ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller - Vimarsana News

Telix Pharmaceuticals Limited: ZIRCON Phase III Kidney Cancer Imaging Study Presented at AUA: New Data Confirms Efficacy in Masses 2cm or Smaller

MELBOURNE, Australia, May 1, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces additional positive results from its completed pivotal Phase III

First Study to Evaluate JELMYTO® Use Post-Complete Endoscopic Ablation Reports 69% of Patients were Disease Free at the Time of First Endoscopic Evaluation - Vimarsana News

First Study to Evaluate JELMYTO® Use Post-Complete Endoscopic Ablation Reports 69% of Patients were Disease Free at the Time of First Endoscopic Evaluation

New Retrospective Study Presented at AUA 2023 Reports Use of JELMYTO in Treating Patients with Upper Tract Urothelial Cancer After Complete Endoscopic Ablation ... | May 1, 2023

Three Abstracts Focusing on the Clinical Utility of Veracyte's Genomic Tests in ILD and Lung Cancer To Be Presented at ATS 2023 International Conference - Vimarsana News

Three Abstracts Focusing on the Clinical Utility of Veracyte's Genomic Tests in ILD and Lung Cancer To Be Presented at ATS 2023 International Conference

Veracyte, Inc. today announced that three abstracts focused on the company’s genomic tests for interstitial lung disease and lung cancer will be presented at the American Thoracic Society ... | May 1, 2023